The healthcare booking platform has now raised $120m this year, after closing a series C round led by Tencent that also featured Google Capital.

Blue Cross Blue Shield of Massachusetts was among the series B-1 investors, adding to the $17m of series B cash secured by InfoBionic in April 2014.

Cambridge University licenses Wizard, an app for treating schizophrenia, to game developer Peak.

The oversubscribed series A round featured Zaffre Investments, the corporate venturing arm of insurance provider Blue Cross Blue Shield.

Kyee, the SoftBank-backed developer of a range of healthcare-focused management software, has now raised nearly $60m since it was founded.

The Celgene and Sorrento-backed immunotherapy drug developer initially raised $207m when it floated on Nasdaq last week.

Almirall invested $15m in dermatological products manufacturer Suneva as part of a larger debt and equity round.